Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)
Clinical trial NCT03446547 · COMPLETED
Trial details
- NCT number
- NCT03446547
- Sponsor
- Vastra Gotaland Region
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2025-10-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.